Concepedia

Author

Betsy LaPlant

Mayo Clinic

Also Known As

B LaPlant, B R LaPlant, B. LaPlant, B. Laplant, B. R. LaPlant, B. R. Laplant, B.R. LaPlant, BETSY LAPLANT, Betsy LaPlant, Betsy Laplant

241

Publications

7.2K

Citations

44

H-Index

64

Concepts

All Affiliations

Mayo ClinicMayo Clinic in ArizonaMayo Clinic in FloridaWinnMedWashington University in St. Louis
BL

About

Betsy LaPlant is an author at Mayo Clinic specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

23

38

2.2K

2

Health Sciences

10

10

569

3

Allergy

2

2

97

4

Education

1

1

52

5

Nursing

1

1

52

Betsy LaPlant

×

99

Publications

6.8K

Citations

43

H-Index

YearCitations

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Wei Ding, Betsy LaPlant, Timothy G. Call,

Blood

2017

411

Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study

Grzegorz S. Nowakowski, Betsy LaPlant, William R. Macon,

Journal of Clinical Oncology

2014

362

Phase I Study of Ipilimumab, an Anti–CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non–Hodgkin Lymphoma

Stephen M. Ansell, Sara A. Hurvitz, Patricia Koenig,

Clinical Cancer Research

2009

330

The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme

Karla V. Ballman, Jan C. Buckner, Paul D. Brown,

Neuro-Oncology

2006

310

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma

Thomas E. Witzig, Craig B. Reeder, Betsy LaPlant,

Leukemia

2010

298

Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma

Shaji Kumar, Betsy LaPlant, Wee Joo Chng,

Blood

2014

248

A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma

Patrick B. Johnston, David J. Inwards, Joseph P. Colgan,

American Journal of Hematology

2010

219

Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma

Yuan Xiao Zhu, Esteban Braggio, Chang-Xin Shi,

Blood

2014

210

Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic Lymphocytic Leukemia

Tait D. Shanafelt, Tim G. Call, Clive S. Zent,

Journal of Clinical Oncology

2009

182

Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia

Tait D. Shanafelt, Timothy G. Call, Clive S. Zent,

Cancer

2012

165

Page 1